Incidence and Prognostic Value of Known Genetic Aberrations in Patients with Acute Myeloid Leukemia--a Two Year Study

Autor: J, Vaskova, K, Dubayova, G, Cakanova, I, Luckova, I, Bochova, G, Novotna, J, Sabo, S, Palasthy, E, Tothova, N, Stecova, A, Karabinos

Publikováno v: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 28(4)

In this work, we evaluated the incidence and prognostic value of several genetic aberrations in patients with a diagnosis of acute myeloid leukemia (AML).We analysed 90 patients: 42 males (mean age 54.5 years) and 48 females (mean age 59 years), with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6bf9e00de2e417859c142ad3ef7bebde
https://pubmed.ncbi.nlm.nih.gov/26299742

A novel way to monitor urine concentration: fluorescent concentration matrices.

Autor: Dubayova K; SEMBID, Spolocnost s Rucenim Obmedzenym, Limited Liability Company, Research Center of Applied Biomedical Diagnostics , Kosice, Slovak Republic, Slovakia ., Luckova I; SEMBID, Spolocnost s Rucenim Obmedzenym, Limited Liability Company , Research Center of Applied Biomedical Diagnostics, Kosice, Slovak Republic, Slovakia ., Sabo J; Faculty, Department of Medical Biophysics, Faculty of Medicine, Pavol Jozef Safarik University in Kosice , Slovak Republic, Slovakia ., Karabinos A; SEMBID, Spolocnost s Rucenim Obmedzenym, Limited Liability Company, Research Center of Applied Biomedical Diagnostics , Kosice, Slovak Republic, Slovakia .

Publikováno v: Journal of clinical and diagnostic research : JCDR [J Clin Diagn Res] 2015 Jan; Vol. 9 (1), pp. BC11-4. Date of Electronic Publication: 2015 Jan 01.